Full Text View
Tabular View
No Study Results Posted
Related Studies
Eflornithine + Nifurtimox Late-Stage Human African Trypanosomiasis (HAT)in West Nile, Uganda (NECS)
This study has been terminated.
( Because of unexpectedly reduced disease prevalence in the study area, a pragmatic decision was taken to terminate recruitment in March 2003. )
Study NCT00489658   Information provided by Epicentre
First Received: June 20, 2007   No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Trypanosomiasis, African
Additional conditions recognized in this trial
Trypanosomiasis
More general conditions related to this trial
Mastigophora Infections
Parasitic Diseases
Protozoan Infections
Sarcomastigophora Infections
Additional drug interventions recognized in this trial
Eflornithine
Nifurtimox
More general drug interventions related to this trial
Anti-Infective Agents
Antineoplastic Agents
Antiparasitic Agents
Antiprotozoal Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Trypanocidal Agents
Sponsors listed in this trial
Epicentre
Medecins Sans Frontieres


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services